Covered recipient · General Payments record
GRACE STEPHAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$932.43
- Reported across 48 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $236.67 | 14 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $86.87 | 5 |
| Lilly USA, LLC | $50.86 | 3 |
| ABBVIE INC. | $34.75 | 2 |
| Amgen Inc. | $29.02 | 2 |
| Esperion Therapeutics, Inc. | $19.50 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.02 | 01/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204405021 | CMS |
| ABBVIE INC. | $16.73 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204405025 | CMS |
| Amgen Inc. | $14.37 | 04/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227099672 | CMS |
| Amgen Inc. | $14.65 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227099670 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.67 | 02/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222953195 | CMS |
| Esperion Therapeutics, Inc. | $19.50 | 04/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243976601 | CMS |
| Lilly USA, LLC | $17.86 | 01/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186636057 | CMS |
| Lilly USA, LLC | $16.59 | 02/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186636061 | CMS |
| Lilly USA, LLC | $16.41 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186636059 | CMS |
| Novo Nordisk Inc | $16.79 | 01/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188186102 | CMS |
| Novo Nordisk Inc | $18.34 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188190360 | CMS |
| Novo Nordisk Inc | $17.54 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188860124 | CMS |
| Novo Nordisk Inc | $17.21 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188191376 | CMS |
| Novo Nordisk Inc | $16.99 | 05/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188306051 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.